H
Hospital das Clinicas da Universidade Federal de Goias | Centro de Pesquisa em Cardiologia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tolvaptan
Treprostinil
Olpasiran
Milvexian
Ixazomib
UT-15C
Parent organization
This site is a part of Hospital das Clinicas da Universidade Federal de Goias
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 8 total trials
The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...
Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems